NEW YORK / LONDON (IT BOLTWISE) – A US startup is causing a stir by offering the genetic optimization of embryos. Nucleus Genomics promises to predict babies’ future size and intelligence, raising ethical concerns.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
A US startup called Nucleus Genomics has sparked a heated debate by offering the possibility of genetically optimizing embryos. The company advertises predicting characteristics such as height and intelligence of future babies, which raises ethical questions. The company’s advertisement, which can be seen on the New York subway, encourages potential parents to genetically optimize their future child.
For $8,999, couples undergoing in vitro fertilization (IVF) can use the startup’s service, which includes full DNA sequencing of up to 20 embryos. In addition to examining health conditions, physical characteristics such as eye and hair color are also analyzed. According to Nucleus Genomics, the company offers over 2,000 genetic analyzes ranging from hereditary diseases to cancer to cognitive ability.
Despite criticism from some users on social media, Nucleus Genomics’ advertising campaign has sparked serious interest among prospective parents. Since ads began on November 14, the company has seen a 1,700 percent increase in sales. This development raises questions about the ethical implications and social impact of such genetic services.
In parallel, there are efforts to recreate human DNA from scratch. The Wellcome Trust, the world’s largest medical charity, has committed £10 million to a project that aims to create a fully synthetic human chromosome. In the long term, these developments could lead to new therapies that make aging healthier and reduce diseases in old age.
Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Controversy over genetic optimization of embryos by US startup”.